Verici Dx is a development stage company with a portfolio of products that aims to enable the end-to-end monitoring of organ rejection indicators for patients undergoing kidney transplant surgery. It has raised £10m gross via a placing and subscription to take advantage of the expanded opportunities as outlined in its recent update and to accelerate development and commercialisation of its key assets. We reiterate our Buy recommendation, with an updated Target Price of 61p and see substantial po ....
07 Mar 2022
£10m raise to accelerate and broaden platform
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
£10m raise to accelerate and broaden platform
Verici Dx Plc (VRCI:LON) | 8.0 0 0.0% | Mkt Cap: 19.4m
- Published:
07 Mar 2022 -
Author:
Chris Glasper -
Pages:
3
Verici Dx is a development stage company with a portfolio of products that aims to enable the end-to-end monitoring of organ rejection indicators for patients undergoing kidney transplant surgery. It has raised £10m gross via a placing and subscription to take advantage of the expanded opportunities as outlined in its recent update and to accelerate development and commercialisation of its key assets. We reiterate our Buy recommendation, with an updated Target Price of 61p and see substantial po ....